| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Calcium signaling pathway |
7 genes: CHRM2, GNAL, MYLK, ATP2B4, PLCB4, PRKACB, CAMK2D
|
0.000416 |
| Wnt signaling pathway |
6 genes: NFAT5, PLCB4, PPP2R5C, PRKACB, CAMK2D, CCND2
|
0.001052 |
| Long.term potentiation |
4 genes: RPS6KA6, PLCB4, PRKACB, CAMK2D
|
0.001992 |
| Gastric acid secretion |
4 genes: MYLK, PLCB4, PRKACB, CAMK2D
|
0.002443 |
| Neurotrophin signaling pathway |
5 genes: FOXO3, RPS6KA6, NTRK3, CAMK2D, PIK3R3
|
0.00287 |
| Focal adhesion |
6 genes: ARHGAP5, MYLK, PDPK1, PIK3R3, ACTN2, CCND2
|
0.004304 |
| Regulation of actin cytoskeleton |
6 genes: CHRM2, ARHGEF12, MYLK, PIK3R3, ACTN2, WASL
|
0.005957 |
| Jak.STAT signaling pathway |
5 genes: IL6ST, LIFR, MPL, PIK3R3, CCND2
|
0.006663 |
| mTOR signaling pathway |
3 genes: RPS6KA6, PDPK1, PIK3R3
|
0.007245 |
| Oocyte meiosis |
4 genes: RPS6KA6, PPP2R5C, PRKACB, CAMK2D
|
0.01122 |
| Vascular smooth muscle contraction |
4 genes: ARHGEF12, MYLK, PLCB4, PRKACB
|
0.0119 |
| Chemokine signaling pathway |
5 genes: FOXO3, PLCB4, PRKACB, PIK3R3, WASL
|
0.01483 |
| Axon guidance |
4 genes: NFAT5, ARHGEF12, ABLIM1, PLXNA2
|
0.01742 |
| Adherens junction |
3 genes: TJP1, ACTN2, WASL
|
0.01817 |
| Insulin signaling pathway |
4 genes: PDPK1, PRKACB, PRKAR2A, PIK3R3
|
0.02118 |
| Progesterone.mediated oocyte maturation |
3 genes: RPS6KA6, PRKACB, PIK3R3
|
0.02869 |
| Hippo signaling pathway |
4 genes: YAP1, DLG2, TEAD1, CCND2
|
0.0301 |
| Apoptosis |
3 genes: PRKACB, PRKAR2A, PIK3R3
|
0.0304 |
| Salivary secretion |
3 genes: ATP2B4, PLCB4, PRKACB
|
0.0304 |
| Cysteine and methionine metabolism |
2 genes: AHCYL2, MTR
|
0.03054 |
| Gap junction |
3 genes: PLCB4, PRKACB, TJP1
|
0.03128 |
| Aldosterone.regulated sodium reabsorption |
2 genes: PDPK1, PIK3R3
|
0.04052 |
| GnRH signaling pathway |
3 genes: PLCB4, PRKACB, CAMK2D
|
0.04181 |
| Melanogenesis |
3 genes: PLCB4, PRKACB, CAMK2D
|
0.04181 |